hotspot -WSS

hotspot

author：focus 2025-10-01 17:19:53 - browse：55

Novo Nordisk headquarters -- health coverage from STAT — LISELOTTE SABROE/Scanpix/AFP via Getty Images

LEXINGTON, Mass. — New obesity drugs like Wegovy and Zepbound are currently taken once a week, indefinitely. But what if they could be taken once a year instead, like a vaccine?

That’s a question that Novo Nordisk, the pharma company behind Wegovy, is exploring as it faces increased competition from other drugmakers aiming to develop similar GLP-1-based treatments for obesity.

“We have a very early think tank on: what would it take us, from a technology point of view and from an ecosystem point of view, to make long-lasting GLP-1 molecules?” Marcus Schindler, Novo’s chief scientific officer, said in an interview with STAT Wednesday. “Could we think about vaccine-like properties, where imagine you had, once a year, an injection with an equivalent of a GLP-1 that really helps you to maintain weight loss and have cardiovascular benefits?”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Readers respond to H5N1 and livestock movements, and more

explore

WSS

JPM 2024: Biotech’s most prolific dealmaker sees a rosy 2024

Anxious about a speech? A startup wants you to pop a minty cardiac drug

Hospital chaplains balance Covid safety with patients’ spiritual needs

It's time to retire 'poor historian' from clinicians' vocabularies

JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

JPM pitch from hospitals? Revenue streams outside of patient care

explore

hotspot

hotspot

Trump demands the U.S. pay no more for drugs than other countries … again

Fauci's latest grilling in Congress: 9 hours, behind closed doors

Affirmative action in medical school literally saved lives

Does Paxlovid work in people vaccinated against Covid

Medicare details structure of new drug price negotiation program

Venture capitalist Bob Kocher on the state of digital health

Drug repurposing or repositioning? The language matters

Bird flu: Don't repeat Covid's 'health versus the economy' framing

Continuity nursing helped my family in our darkest PICU moments

Military medical care influenced by rank and race, new study finds

hotspot

Hospital chaplains balance Covid safety with patients’ spiritual needs

Venture capitalist Bob Kocher on the state of digital health

Mayo Clinic partners with supercomputer AI firm Cerebras at JPM

Wearables generate powerful data but its not useful to doctors, yet

With measles on the rise, a personal story of a devastating disease

Hospital chaplains balance Covid safety with patients’ spiritual needs

explore

Wikipedia

Wikipedia

hotspot